Illumina will seek to cut $100 million ... which will include a new multimodal software platform that runs on its current NextSeq and NovaSeq hardware. The company is also developing what it ...
(RTTNews) - Illumina, Inc. (ILMN ... a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
The significance of the findings is valuable, with implications for immunotherapy design in pancreatic ductal adenocarcinoma. The evidence was considered incomplete and partially supportive of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results